Access cutting-edge multiple myeloma treatment through this clinical trial at a research site in Berkeley. Study-provided care at no cost to qualified participants.
Access multiple myeloma specialists in Berkeley at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple myeloma treatment provided free
The purpose of this study is to compare the efficacy of teclistamab with PVd/Kd in Part 1 and to further characterize safety and efficacy of an alternative dosing for teclistamab in Part 2 in participants with relapsed or refractory multiple myeloma.
Sponsor: Janssen Research & Development, LLC
Check if you qualify for this multiple myeloma clinical trial in Berkeley, CA
If you're searching for multiple myeloma treatment options in Berkeley, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Berkeley research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple myeloma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.